Billionaires Holding OREX

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 123.2M
    Shares Outstanding

  • 29.17M
    Market Cap

News & Insights

ABOUT

OREX

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include NB32, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and E...

Procter & Gamble Co.'s Worst Moves in 2016

NEWS

US STOCKS-Wall St set to open flat as investors test rally

READ MORE